Ngā hua rapu - Jean‐Pierre Pignon
- E whakaatu ana i te 1 - 20 hua o te 68
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
Mortality factors associated with chronic pancreatitis mā Philippe Lévy, Chantal Milan, Jean‐Pierre Pignon, A Baetz, P Bernadès
I whakaputaina 1989Artigo -
4
-
5
-
6
Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: Preliminary correlations with local control and overall survival mā T. Girinsky, Richard Lubin, Jean‐Pierre Pignon, N. Chavaudra, J Gazeau, Bernard Dubray, Jean‐Marc Cosset, Gèrard Socié, Bernard Fertil
I whakaputaina 1993Artigo -
7
-
8
-
9
-
10
Progression-Free Survival Is a Surrogate for Survival in Advanced Colorectal Cancer mā Marc Buyse, Tomasz Burzykowski, Kevin Carroll, Stefan Michiels, Daniel J. Sargent, Langdon L. Miller, Gary Elfring, Jean‐Pierre Pignon, Pascal Piedbois
I whakaputaina 2007Artigo -
11
Modulation of Fluorouracil by Leucovorin in Patients With Advanced Colorectal Cancer: An Updated Meta-Analysis mā P. Thirion, Stefan Michiels, Jean‐Pierre Pignon, Marc Buyse, A.C. Braud, Robert W. Carlson, M. O’Connell, Penny Sargent, P Piedbois
I whakaputaina 2004Revisão -
12
Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial mā Valérie Boige, Jean‐Luc Raoul, Jean‐Pierre Pignon, O. Bouché, J.-F. Blanc, Laëtitia Dahan, J-L Jouve, N. Dupouy, Michel Ducreux
I whakaputaina 2007Artigo -
13
Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis mā François Janot, Jerzy Klijanienko, Anna Russo, Julie Mamet, Filippo de Braud, A. K. El-Naggar, Jean‐Pierre Pignon, B Luboïnski, Esteban Cvitkovic
I whakaputaina 1996Artigo -
14
Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution mā D. Élias, M. Bonnay, J.M. Puizillou, S. Antoun, Sylvie Demirdjian, A. El Otmany, Jean‐Pierre Pignon, L. Drouard-Troalen, J.F. Ouellet, Michel Ducreux
I whakaputaina 2002Artigo -
15
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small... mā J.-C. Soria, Audrey Mauguen, Martin Reck, Alan B. Sandler, Nagahiro Saijo, David H. Johnson, Domnita-Ileana Burcoveanu, M. Fukuoka, Benjamin Besse, Jean‐Pierre Pignon
I whakaputaina 2012Revisão -
16
Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in... mā Pierre Blanchard, Jean Bourhis, Benjamin Lacas, Marshall R. Posner, Jan B. Vermorken, Juan Jesús Cruz, Abderrahmane Bourredjem, G. Calais, Adriano Paccagnella, Ricardo Hitt, Jean‐Pierre Pignon
I whakaputaina 2013Revisão -
17
Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised tri... mā Silvy Laporte, Pierre Squifflet, Noémie Baroux, Frank V. Fossella, Vassilis Georgoulias, Jean-Louis Pujol, Jean‐Yves Douillard, Shinzohy Kudoh, Jean‐Pierre Pignon, Emmanuel Quinaux, Marc Buyse
I whakaputaina 2013Artigo -
18
Efficacy, Safety, and Biomarkers of Single-Agent Bevacizumab Therapy in Patients with Advanced Hepatocellular Carcinoma mā Valérie Boige, David Malka, Abderrahmane Bourredjem, Clarisse Dromain, Charlotte Baey, Nathalie Jacques, Jean‐Pierre Pignon, Nadège Vimond, N. Bouvet-Forteau, Thierry de Baère, Michel Ducreux, Françoise Farace
I whakaputaina 2012Artigo -
19
Effect of Amifostine on Survival Among Patients Treated With Radiotherapy: A Meta-Analysis of Individual Patient Data mā Jean Bourhis, Pierre Blanchard, E. Maillard, David M. Brizel, Benjamin Movsas, Jens Buentzel, Johannes A. Langendijk, Ritsuko Komaki, Swan Swan Leong, Peter C. Levendag, Jean‐Pierre Pignon
I whakaputaina 2011Revisão -
20
Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission mā Anne Aupérin, R. Arriagada, Jean‐Pierre Pignon, C. Le Péchoux, Anna Gregor, Richard Stephens, Paul E.G. Kristjansen, Bruce E. Johnson, Hiroshi Ueoka, Henry Wagner, Joseph Aisner
I whakaputaina 1999Revisão
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Oncology
Cancer
Chemotherapy
Confidence interval
Lung cancer
Hazard ratio
Surgery
Randomized controlled trial
Radiation therapy
Meta-analysis
Biology
Clinical trial
Colorectal cancer
Cisplatin
Gastroenterology
Adjuvant
Paleontology
Proportional hazards model
Stage (stratigraphy)
Clinical endpoint
Head and neck cancer
Gene
Adenocarcinoma
Fluorouracil
KRAS
Pathology
Biochemistry
Breast cancer